{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:53:04Z","timestamp":1792569184681,"version":"4.5.0"},"reference-count":20,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2020,8,10]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Current guidelines recommend an initial pleural aspiration in the investigation and management of suspected malignant pleural effusions (MPEs) with the aim of establishing a diagnosis, identifying non-expansile lung (NEL) and, at times, providing a therapeutic procedure. A wealth of research has been published since the guidelines suggesting that results and outcomes from an aspiration may not always provide sufficient information to guide management. It is important to establish the validity of these findings in a \u2018real world\u2019 population.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective analysis was conducted of all patients who underwent pleural fluid (PF) sampling, in a single centre, over 3 years to determine the utility of the initial aspiration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A diagnosis of MPE was confirmed in 230\/998 (23%) cases, a further 95\/998 (9.5%) were presumed to represent MPE. Transudative biochemistry was found in 3% of cases of confirmed MPE. Positive PF cytology was only sufficient to guide management in 45\/140 (32%) cases. Evidence of pleural thickening on CT was associated with both negative cytology (\u03c7<jats:sup>2<\/jats:sup> 1df=26.27, p&lt;0.001) and insufficient samples (\u03c7<jats:sup>2<\/jats:sup> 1df=10.39, p=0.001). In NEL 44.4% of patients did not require further procedures after pleurodesis compared with 72.7% of those with expansile lung (\u03c7<jats:sup>2<\/jats:sup> 1df=5.49, p=0.019). In patients who required a combined diagnostic and therapeutic aspiration 106\/113 (93.8%) required further pleural procedures.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>An initial pleural aspiration does not achieve either definitive diagnosis or therapy in the majority of patients. A new pathway prioritising symptom management while reducing procedures should be considered.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2020-000701","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T19:03:45Z","timestamp":1600801425000},"page":"e000701","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Critical analysis of the utility of initial pleural aspiration in the diagnosis and management of suspected malignant pleural effusion"],"prefix":"10.1136","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-3151","authenticated-orcid":false,"given":"Rachel Mary","family":"Mercer","sequence":"first","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"},{"name":"School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK"},{"name":"Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Varatharajah","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Shepherd","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olalla","family":"Castro-A\u00f1\u00f3n","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"},{"name":"Respiratory Division and Sleep Disorders Unit, Lucus Augusti University Hospital, Lugo, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-478X","authenticated-orcid":false,"given":"David J","family":"McCracken","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dudina","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Addala","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatoula","family":"Tsikrika","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"},{"name":"Pulmonary Division, Department of Critical Care, Medical School, National and Kapodistrian, University of Athens, Evangelismos General Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-5875","authenticated-orcid":false,"given":"Vineeth","family":"George","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Banka","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachelle","family":"Asciak","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-6548","authenticated-orcid":false,"given":"Maged","family":"Hassan","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"},{"name":"Chest Diseases Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hallifax","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eihab O","family":"Bedawi","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis Kay","family":"Shute","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib M","family":"Rahman","sequence":"additional","affiliation":[{"name":"Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford, United Kingdom"},{"name":"Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom"},{"name":"Oxford NIHR Biomedical Research Centre, University of Oxford and Oxford University Hospitals, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"2025083110130627000_7.1.e000701.1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/imj.13991","article-title":"Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience","volume":"48","author":"Loveland","year":"2018","journal-title":"Intern Med J"},{"key":"2025083110130627000_7.1.e000701.2","first-page":"ii4","article-title":"Investigation of a unilateral pleural effusion in adults: British thoracic Society pleural disease guideline 2010","volume":"65(Suppl 2)","author":"Hooper","year":"2010","journal-title":"Thorax"},{"key":"2025083110130627000_7.1.e000701.3","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199801000-00004"},{"key":"2025083110130627000_7.1.e000701.4","first-page":"113","article-title":"[Cuttoff values of biochemical tests on pleural fluid: their usefulness in differential diagnosis of 1,040 patients with pleural effusion]","volume":"21","author":"Porcel-P\u00e9rez","year":"2004","journal-title":"An Med Interna"},{"key":"2025083110130627000_7.1.e000701.5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lungcan.2019.05.017","article-title":"Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups","volume":"133","author":"Tsim","year":"2019","journal-title":"Lung Cancer"},{"key":"2025083110130627000_7.1.e000701.6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2025083110130627000_7.1.e000701.7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2016-000171"},{"key":"2025083110130627000_7.1.e000701.8","first-page":"ii32","article-title":"Management of a malignant pleural effusion: British thoracic Society pleural disease guideline 2010","volume":"65(Suppl 2)","author":"Roberts","year":"2010","journal-title":"Thorax"},{"key":"2025083110130627000_7.1.e000701.9","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.154.3.2106209"},{"key":"2025083110130627000_7.1.e000701.10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/crj.12940","article-title":"What is the significance of non-specific pleuritis? A trick question","volume":"12","author":"Janssen","year":"2018","journal-title":"Clin Respir J"},{"key":"2025083110130627000_7.1.e000701.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.16840"},{"key":"2025083110130627000_7.1.e000701.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2017-000266"},{"key":"2025083110130627000_7.1.e000701.13","first-page":"42","article-title":"Diagnosing malignant pleural effusions: how do we compare?","volume":"126","author":"Lim","year":"2013","journal-title":"N Z Med J"},{"key":"2025083110130627000_7.1.e000701.14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01254-2018","article-title":"Investigating unilateral pleural effusions: the role of cytology","volume":"52","author":"Arnold","year":"2018","journal-title":"Eur Respir J"},{"key":"2025083110130627000_7.1.e000701.15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/resp.13681","article-title":"Inter-Observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion","volume":"25","author":"Martin","year":"2020","journal-title":"Respirology"},{"key":"2025083110130627000_7.1.e000701.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1895-3"},{"key":"2025083110130627000_7.1.e000701.17","first-page":"995","article-title":"Diagnostic delay causes more psychological distress in female than in male cancer patients","volume":"16","author":"Risberg","year":"1996","journal-title":"Anticancer Res"},{"key":"2025083110130627000_7.1.e000701.18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2876"},{"key":"2025083110130627000_7.1.e000701.19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chest.2019.07.010","article-title":"Pre-EDIT: a randomized feasibility trial of Elastance-Directed intrapleural catheter or talc pleurodesis in malignant pleural effusion","volume":"156","author":"Martin","year":"2019","journal-title":"Chest"},{"key":"2025083110130627000_7.1.e000701.20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N Engl J Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2020-000701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:13:13Z","timestamp":1756660393000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2020-000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,9,22]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjresp-2020-000701"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2020-000701","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}